4//SEC Filing
ROCKLAGE SCOTT M 4
Accession 0001415889-25-019677
CIK 0001689375other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:25 PM ET
Size
16.3 KB
Accession
0001415889-25-019677
Insider Transaction Report
Form 4
5AM Opportunities I, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.) - Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total
5AM Opportunities I (GP), LLC
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total - Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.)
Schwab Andrew J.
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total - Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.)
5AM Ventures V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total - Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.)
5AM Partners V, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.) - Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total
ROCKLAGE SCOTT M
10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total - Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.)
Footnotes (2)
- [F1]Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
- [F2]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001219014
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 5:25 PM ET
- Size
- 16.3 KB